» Articles » PMID: 33147824

Efficacy of Porcine Epidemic Diarrhea Vaccines: A Systematic Review and Meta-Analysis

Overview
Date 2020 Nov 5
PMID 33147824
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Porcine epidemic diarrhea (PED) is a devastating disease that causes considerable economic damage to the global pig industry. Although the causative agent, the porcine epidemic diarrhea virus (PEDV), was identified about a half century ago, there is still much debate on the preventive measures against the disease, especially regarding the PED vaccine. Recent reports on PEDV variants make the vaccination for PEDV more confusing. Therefore, we systematically reviewed published articles on PED and vaccines against the disease and performed a meta-analysis of vaccine efficacy based on the clinical signs, fecal score and survival rates. A total of 299 articles on the efficacy of PED vaccines were found online, and 21 articles were selected that fulfilled all the criteria. A meta-analysis was performed on the 21 articles based on the fecal scores and survival rates. This analysis showed the efficacy of PED vaccines, and no significant differences in the efficacy depending on vaccine type (killed vs. live) or administration route (intramuscular vs. oral) were found. The results from our study suggest that any vaccination against PED is a useful strategy to control the disease regardless of the type of vaccine and administration route.

Citing Articles

Lactate is useful for the efficient replication of porcine epidemic diarrhea virus in cell culture.

Wuri N, Gou H, Zhang B, Wang M, Wang S, Zhang W Front Vet Sci. 2023; 10:1116695.

PMID: 36861007 PMC: 9968725. DOI: 10.3389/fvets.2023.1116695.


Resistance of Field-Isolated Porcine Epidemic Diarrhea Virus to Interferon and Neutralizing Antibody.

Park J, Shin H Vet Sci. 2022; 9(12).

PMID: 36548851 PMC: 9783040. DOI: 10.3390/vetsci9120690.


Development of a Genetically Engineered Bivalent Vaccine against Porcine Epidemic Diarrhea Virus and Porcine Rotavirus.

Li W, Lei M, Li Z, Li H, Liu Z, He Q Viruses. 2022; 14(8).

PMID: 36016368 PMC: 9413861. DOI: 10.3390/v14081746.


Isolation and oral immunogenicity assessment of porcine epidemic diarrhea virus NH-TA2020 strain: One of the predominant strains circulating in China from 2017 to 2021.

Li X, Li Y, Huang J, Yao Y, Zhao W, Zhang Y Virol Sin. 2022; 37(5):646-655.

PMID: 35961502 PMC: 9583181. DOI: 10.1016/j.virs.2022.08.002.


Enhancing epitope of PEDV spike protein.

Thavorasak T, Chulanetra M, Glab-Ampai K, Mahasongkram K, Sae-Lim N, Teeranitayatarn K Front Microbiol. 2022; 13:933249.

PMID: 35935230 PMC: 9355140. DOI: 10.3389/fmicb.2022.933249.


References
1.
Lee S, Yang D, Kim H, Cho I . Efficacy of inactivated variant porcine epidemic diarrhea virus vaccines in growing pigs. Clin Exp Vaccine Res. 2018; 7(1):61-69. PMC: 5795046. DOI: 10.7774/cevr.2018.7.1.61. View

2.
Duval S, Tweedie R . Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000; 56(2):455-63. DOI: 10.1111/j.0006-341x.2000.00455.x. View

3.
Wood E . An apparently new syndrome of porcine epidemic diarrhoea. Vet Rec. 1977; 100(12):243-4. DOI: 10.1136/vr.100.12.243. View

4.
Lee D, Park C, Kim S, Lee C . Heterogeneity in spike protein genes of porcine epidemic diarrhea viruses isolated in Korea. Virus Res. 2010; 149(2):175-82. PMC: 7114470. DOI: 10.1016/j.virusres.2010.01.015. View

5.
Kweon C, Kwon B, Lee J, Kwon G, Kang Y . Derivation of attenuated porcine epidemic diarrhea virus (PEDV) as vaccine candidate. Vaccine. 1999; 17(20-21):2546-53. PMC: 7125954. DOI: 10.1016/s0264-410x(99)00059-6. View